Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Holding it together: Cell adhesion and immunobullous diseases
Description
The presentation by Peter Markovich covers the importance of cell adhesion structures in the skin, specifically focusing on how they are affected in immunobullous diseases. He explains how the skin's layered structure, including desmosomes and the basement membrane, provides protection against environmental damage and how disruptions in these structures can lead to blistering disorders. Markovich categorizes these diseases into acquired (like pemphigus and pemphigoid) and inherited conditions (like epidermolysis bullosa). He discusses the diagnostic importance of immunopathological testing, emphasizing direct immunofluorescence and serological tests for accurate diagnosis. The presentation details various blistering conditions, including pemphigus foliaceous and vulgaris, highlighting their clinical features, variations, and treatment approaches. Markovich notes the advancements in gene therapy for inherited blistering disorders, showcasing promising results from innovative treatments that restore critical adhesion proteins in patients with conditions like dystrophic epidermolysis bullosa. He concludes by underscoring the evolutionary understanding of skin structure and its application to improving patient outcomes in dermatological conditions.
View moreConclusions
- Pemphigus diseases, including vulgaris and foliaceous, are characterized by autoantibodies against desmogleins, leading to blister formation.
- Different distributions of desmogleins in skin and mucosa explain why pemphigus vulgaris affects mucosal membranes while foliaceous does not.
- Acquiring a correct immunopathological diagnosis is crucial for effective treatment of immunobullous diseases to avoid unnecessary morbidity from misdiagnosis.
- The Pemphigoid diseases group, including bullous pemphigoid and cicatricial pemphigoid, involves different target autoantigens in the basement membrane, leading to subepidermal blistering.
- Direct immunofluorescence and immunologic testing are necessary for the diagnosis of autoimmune blistering diseases, highlighting the importance of immunoglobulin interaction with skin antigens.
- Understanding the structure of desmosomes and the basement membrane is key to comprehending the etiology of blistering diseases.
- Gene therapy approaches, such as using HSV-1 vectors to deliver collagen genes directly to the skin, show promise for treating conditions like dystrophic epidermolysis bullosa.
- Recent advancements in gene therapy for epidermolysis bullosa have led to successful outcomes and highlight the potential for future treatments in genetic skin disorders.
- Amagai and co-workers
- Stanley et al.
- Jannetti Publications, Inc.
- Tobias Hirsch et al., doi:10.1038/nature24487
- Zurab Siprashvili et al., JAMA
- Henry Liu et al., Nat Med. 2022; 28: 780-788